Ionis Pharmaceuticals Inc. buy BMO Capital Markets
Start price
03.09.25
/
50%
€51.62
Target price
03.09.26
€60.18
Performance (%)
24.49%
Price
08.05.26
€64.26
Summary
This prediction is currently active. The prediction currently has a performance of 24.49%. This prediction currently runs until 03.09.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ionis Pharmaceuticals Inc. | 0.816% | 0.816% |
| iShares Core DAX® | 0,22 % | 1,49 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % |
| iShares S&P 500 | 2,17 % | 8,06 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Ionis Pharmaceuticals Inc. diskutieren
Ionis Pharmaceuticals (NASDAQ:IONS) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $70.00 price target on the stock.
Ratings data for IONS provided by MarketBeat